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INTRODUCTION
The phenomenon of age-related muscle wasting has been long recognized
by geriatricians, rehabilitation specialists,
and public health practitioners. However,
Federal agencies are slow to recognize sarcopenia as a diagnostic term despite the
ubiquitous observation of muscle loss as
a signature event of aging. The formal
adoption of sarcopenia as a clinical diagnosis has been complicated by its evolving operational definition and the varied
approaches to the assessment of lean body
mass (LBM). Currently, formal assessments of LBM rarely occur within the context of standard geriatric care. The failure
to adequately assess muscle tissue within
the larger context of geriatric medical care
has significant public health implications
given the importance of adequate muscle function for “successful aging” and the
maintenance of independent living (Visser
and Schaap, 2011).
The prevalence of sarcopenia is approximately 25% of the U.S. population over
70 years of age (Baumgartner et al., 1998;
Lorenzo, 2009). Additionally, U.S. health
care expenditures ascribed to sarcopenia, based on the Third National Health
and Nutritional Examination Survey
(NHANES III) data, have been conservatively estimated at 11.8 billion dollars
(Janssen et al., 2004a). Given the national
trends in the Veteran population with
respect to age, reported disability levels,
and increased representation of African
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American soldiers, the potential impact
of sarcopenia on the Veterans Health
Administration (VHA) healthcare system
merits consideration.

AFRICAN AMERICANS AND THE VHA
HEALTHCARE SYSTEM
The total Veteran population was estimated to be over 22 million in 2012
which also includes approximately 2.2
million women. There was significant
minority representation among Veterans
during this same period with African
Americans members totaling 2.6 million men and 430,000 women. The 2011
Veteran Population Projection Model (VA
Office of the Actuary, 2011) projects
a nearly 35% decrease in the total
Veteran population between 2013 and
2040. Nonetheless, this population trend
will be countered by an anticipated concomitant increase in the percentage of
minority Veterans from 21 to 34% during
this same time period. African Americans
will constitute the largest proportion of
this projected demographic shift in the
Veteran population (National Center for
Veterans Analysis and Statistics, 2011).
These changes reflect the advent of the
All-Voluntary Force and recent military
conflicts such as the Gulf War I and II
which were notable for the high proportion of participating minority service
members with nearly one in three soldiers
being African American (Census Bureau,
2010). It is important to note that the

Veteran population is older than the general population with a median age of
62 in comparison with a non-Veteran
median age of 43. The oldest Veterans
reflect a larger proportion of Caucasians
(Census Bureau, 2010; National Center for
Veterans Analysis and Statistics, 2011) as
their median age is 64 in comparison to
minority Veterans who have a median age
of 54–57. However, the relatively younger
subset of minority Veterans coupled with
the projected demographic changes suggest that the need to effectively manage
geriatric syndromes in African Americans
within the VHA healthcare system will
continue to increase over time.

SARCOPENIA: DIAGNOSTIC
CONSIDERATIONS FOR AFRICAN
AMERICANS
Sarcopenia is an age-related syndrome
characterized by a decrease in muscle mass
and associated with a loss of strength
and power, diminished functional performance, and increased disability (Newman
et al., 2003; Morley et al., 2011). The observation that basic mobility and independent living status may be more dependent
on lower extremity muscle performance
rather than LBM in older adults (Visser
et al., 2000; Kamel, 2003) was the impetus
for some investigators to ascribe specific
terms (e.g., dynapenia and kratopenia), to
characterize the age-related loss of muscle force and power (Morley et al., 2011).
Moreover, the Foundation for the National
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Institutes of Health Sarcopenia Project has
proposed to qualify sarcopenia as a form of
skeletal muscle function deficit to reflect the
varied etiology of mobility impairments
(Correa-de-Araujo and Hadley, 2014).
The recognition of total body mass or body
fat as independent factors that influence
functional status gave rise to sarcopenic
index measures that combine these variables with estimates of LBM (Newman
et al., 2003). Consensus groups such as the
European Working Group on Sarcopenia
in Older People (EWGSOP) (Cruz-Jentoft
et al., 2010) have proposed a staged diagnostic criteria for sarcopenia that include
elements of LBM, strength, and functional
performance in response to these contemporary research findings (Table 1). These
consensus groups have recommended customary walking speed as a key component of the sarcopenia screening criteria,
and the Society for Sarcopenia, Cachexia
and Wasting Disorders (SSCWD) has
recommended that only older adults with

mobility deficits and/or a history of
falls should be considered for sarcopenia screening (Morley et al., 2011). This
screening model has potential shortcomings that may be cause for concern. Just as
bone fracture is the signal event of osteoporosis, an observed functional limitation
may be deemed a signal event of sarcopenia. Moreover, it remains an open question
if these aforementioned conditions for sarcopenia screening, derived largely from
population-based studies involving relatively healthy community-dwelling adults
(Dam et al., 2014), are appropriate for
usage among a Veteran population with a
high prevalence of comorbid conditions.

RACIAL/ETHNIC CONSIDERATIONS
FOR BODY COMPOSITION
ASSESSMENT
Despite the recent evolution of the
diagnostic criteria for sarcopenia, the
assessment of LBM remains vital to our
understanding and clinical management

of age-related muscle dysfunction. A critical issue to consider in addressing
possible sarcopenia disparities in African
Americans is the influence of racial/ethnic
characteristics on common methods of
body composition assessment. African
Americans have approximately 5–8%
higher levels of muscle mass in comparison to Caucasians based on total body
potassium assessment (TBK), and this difference applies to both men and women
and persists from childhood to old age
(Ortiz et al., 1992). African Americans
may also have 7–10% greater levels of
bone mineral density (BMD) as measured
with dual-energy X-ray absorptiometry
(DXA), even when controlling for LBM
and stature in men (Ettinger et al., 1997).
However, the rate of age-related LBM and
BMD loss may be similar between the two
races (Cohn et al., 1977). In addition, the
distribution of body fat differs between
these groups as Caucasians have greater
skinfold thickness in their chest, abdomen,

Table 1 | Categories of the sarcopenia syndrome based on causative factors, body composition, and stages of severity.
Causative factors

Body composition

Staging

Sarcopenia

LBM loss criterion onlyb

Presarcopenia

LBM loss criterion
onlyb

• Activity-related
• Disease-related
• Nutrition-related

Sarcopenia class:
aLM/h2
• Class I (−1 to −2 SD)
• Class II (↓ −2 SD)

A range of criteria based on
LBM (relative to stature)c

Sarcopenia

LBM loss criterion, and
strength loss or
functional status
criteria metf

Myopenia
All-cause designation,
independent of age

LBM loss, affecting
functional status or
mortality

Sarcopenia class: SMI
• Class I (−1 to −2 SD)
• Class II (↓ −2 SD)

A range of criteria based on
ratio of LBM to body mass
(relative to body mass)d

Severe
Sarcopenia

All criteria are met

Skeletal Muscle
Function Deficit
All-cause designation,
independent of age

Diminished muscle
performancea ,
affecting functional
status

Sarcopenic obesity

LBM maintenance or loss, and
body fat criterion mete

Primary Sarcopenia

Secondary Sarcopenia
Contributing comorbid
factors and behavioral
conditions

a Muscle

Age-related only

performance as measured by a given measure or estimate of strength, power, or capacity (e.g., endurance/fatigue; Correa-de-Araujo and Hadley, 2014).

b Appendicular

lean mass (aLM/h2 ; men and women, respectively): 7.26 and 5.45 kg/m2 (Baumgartner et al., 1998); 6.12 and 5.29 kg/m2 (African American cohort;

Kelly et al., 2009); aLM scaled to body mass index (BMI): 0.789 and 0.512 (aLMBMI ; men and women, respectively; Dam et al., 2014); use of a single criterion
for sarcopenia involving lean body mass (LBM) may include adjustments for height, body fat, and/or body mass by some investigators (Cruz-Jentoft and Morley,
2012).
c Class

I: 8.51–10.75 kg/m2 in men, and 5.76–6.75 kg/m2 in women; Class II: ≤8.50 kg/m2 in men, and ≤5.75 kg/m2 in women (Janssen et al., 2004a,b).

d Class

I: 31–37% in men, and 22–28% in women; Class II: ≤30% in men, and ≤21% in women [SMI, skeletal muscle mass index; (muscle mass/body mass) *

100; Janssen et al., 2002].
e Body

fat percentage (BF%): 27% in men and 38% in women (Baumgartner, 2000); BMI: ≥30 kg/m2 (Schrager et al., 2007); cohort specific criteria: 2 highest

quintiles of BF% and 2 lowest quintiles of lean body mass (Gomez-Cabello et al., 2011).
f Grip strength: <30 kg in men, and <20 kg in women (Murphy et al., 2013); <26 kg in men, and <16 kg in women (Dam et al., 2014); gait speed: <0.8 m/s (Cruz-Jentoft

et al., 2010); gait speed or distance: <1.0 m/s or <400 m during the 6-min walk test (Morley et al., 2011).
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and thighs, whereas African Americans
have greater subscapular skinfold thickness (Zillikens and Conway, 1990; Nindl
et al., 1998). These phenotypic patterns
may confound body composition assessment methods that do not account for
these factors. Consequently, an alternative
LBM density value of 1.13 g/cm3 has been
proposed for African Americans instead of
the 1.10 g/cm3 value typically used in body
composition models (Schutte et al., 1984).
The most common whole body tissue
composition methods used in sarcopenia research include anthropometry,
bioelectrical impedance (BIA), and
DXA. Anthropometry is often used in
community-health settings and constitutes a broad assessment category that
features extremity circumferential measurements, body mass index (BMI), and
skin fold measurements. While circumferential measurements have been shown
to be associated with diminished activities of daily living (ADL) (Baumgartner
et al., 1998), their use as proxy body
composition measures systematically
underestimate LBM in African Americans
based on comparative differences in LBM
density, body fat distribution, and even
relative body proportions (Wagner and
Heyward, 2000). BMI has served as a
valuable predictor of critical health outcomes (Kane et al., 2011), but also does
not account for racial/ethnic differences
in LBM density or body fat distribution
and may overestimate the obesity rates
in African Americans (Kleerekoper et al.,
1994). Skin fold measurements have limitations similar to the aforementioned
anthropometric methods, and have also
been shown to underestimate LBM density in African Americans (Schutte et al.,
1984). In addition, BIA has been used
extensively to characterize body composition in population-based studies (Janssen
et al., 2002, 2004b; Chien et al., 2008).
The interpretation of body composition
data involving African Americans and
BIA measures may be limited due to
assumptions concerning body fat distribution and relative body proportions.
However, Wagner et al. (1997) have
identified a validated predictive model
appropriate for use in this population.
Their use of the Segal adiposity-specific
equations, with expanded categories per
the Stolarczyk modification, yields fairly
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accurate body composition measures for
African Americans, underestimating FFM
by 1.8 kg. While lacking the portability
of anthropometry and BIA, DXA estimates of muscle mass have a high degree
of association with TBK and the imaging
method serves as a direct measure of BMD
(Wagner and Heyward, 2000; Cruz-Jentoft
and Morley, 2012). Therefore, DXA may
not be unduly influenced by racial/ethnic
differences in LBM density and may serve
as an ideal method to assess sarcopenia
in studies with multiracial participants
and for clinical practice in hospital settings (sarcopenic LBM criterion values,
Table 1).

THE PREVALENCE AND
CONSEQUENCES OF SARCOPENIA IN
AFRICAN AMERICANS
Despite the substantial clinical and financial burden attributed to sarcopenia, this
geriatric syndrome remains an underdiagnosed condition and is rarely subject to a systematic screening process as a
part of customary medical care for older
adults (Fielding et al., 2011). The sarcopenia syndrome diminishes functional
independence and results in a 3–4 times
increased likelihood of developing a disability. In addition, sarcopenia may exacerbate hip fracture incidence due to the
loss of requisite strength to maintain
dynamic balance (Kamel, 2003). However,
while some investigators have shown a
significant relationship among diminished
LBM, impaired lower extremity strength,
functional performance, and disability
(Malmstrom et al., 2013), others have
reported that a negligible association exists
between LBM and disability in community dwelling older adults (Visser et al.,
2000). Walking speed, fall risk, negotiating stairs, basic mobility, and independent
living status may be more dependent on
lower extremity strength and power rather
than LBM in older adults (Visser et al.,
2000; Kamel, 2003).
The discordance between the agerelated loss of muscle mass and diminished
function has been observed across ethnic
groups. However, this non-intuitive clinical observation is most evident in African
Americans. Few studies have reported
epidemiological data by ethnic or racial
group for sarcopenia. Investigators using
data from the Health Aging and Body

Composition Study found that 14.3 and
18.4% of African American men and
women, respectively, were classified as sarcopenic when adjusting for height and
body fat (Newman et al., 2003). Others
have noted a prevalence in Caucasians
above 25% for men and women across all
ages, whereas these values were reported
as low as 6–12% in African Americans
(Kan, 2009). Nevertheless, studies involving older, community-dwelling, African
Americans consistently demonstrate that
they have diminished functional performance, and higher levels of dependence
with ADLs and risk of disabling conditions, in comparison to other racial/ethnic
groups (Miller et al., 2005). What accounts
for older African Americans having a
higher prevalence of functional limitations
and ADL difficulty despite their lower
prevalence of sarcopenia?
Both Janssen and Visser have recognized high body fat levels as a confounder
in the investigations into the association of LBM with functional limitations
and disability (Janssen et al., 2002; Visser
et al., 2002). The consideration of body
fat and body mass adds an important
dimension to the sarcopenia syndrome
given that unchanging muscle mass coupled with increased body fat may portend significant functional and metabolic
decline (Cruz-Jentoft and Morley, 2012).
Moreover, myosteatosis (an increased proportion of intramuscular adipose tissue) has been observed in older adults
of African ancestry, and this deleterious
adaptation to aging may occur to a greater
degree in comparison to Caucasians even
when subcutaneous and visceral fat levels are similar among the groups (Song
et al., 2004; Miljkovic-Gacic et al., 2008).
While the higher risk of disabling conditions observed in African Americans likely
involves an array of socioeconomic factors
(Fuller-Thomson et al., 2009), high levels of myosteatosis are strongly associated
with impaired lower extremity function
and may serve as a possible explanation
for the departure in linearity between
muscle wasting and physical performance
(Goodpaster et al., 2001).
Non-contractile features of muscle also
affect health outcomes as age-related
changes in skeletal muscle may be a critical
progenitor of metabolic abnormalities
(Albu et al., 2005). While preliminary
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findings suggest that relative muscle mass
may be more strongly associated with
insulin resistance than strength (Bijlsma
et al., 2013), there are divergent views on
this point (Kamel, 2003; Sayer et al., 2005).
Data from the NHANES III cohort reveal
that sarcopenia is strongly associated with
the homeostasis model assessment of
insulin resistance and higher HbA1C levels in both non-obese and obese individuals under 60 years of age (Srikanthan
et al., 2010). However, the relationship
between sarcopenia and a higher prevalence of type 2 diabetes was only observed
in obese individuals. Miljkovic et al. (2009)
determined that Afro-Caribbean men had
higher myosteatosis levels and a lower
body fat percentage in comparison to
Caucasian men. Myosteatosis was associated with type 2 diabetes in both groups,
but 44% of the Afro-Caribbean men were
diagnosed with the metabolic disorder in
comparison to 13% of the Caucasian men.
While the negative impact of low muscle
mass on glucose homeostasis cannot be
discounted (Bijlsma et al., 2013), excessive
intramuscular adipose tissue and intramyocellular lipid content may disrupt insulin
receptor activity, limit glucose transport,
and potentially result in adipokine release
from local concentrations of adipose tissue
(Miljkovic et al., 2009). The case could be
made to incorporate age-related changes
in muscle quality into the broad view of
the sarcopenia diagnosis. However, more
prospective study will be needed to better
understand the role of myosteatosis in the
pathogenesis of diminished insulin sensitivity and diabetes. Given that African
Americans are 1.6–1.7 times as likely to
have diabetes in comparison to Caucasians
within the VA and civilian population,
it may be a compelling interest of the
Federal health agencies, professional and
scientific organizations, and other stakeholders to study the impact of age-related
muscle changes and how they interact
with racial/ethnic group factors in health
disparities (National Center for Veterans
Analysis and Statistics, 2011).

FUNDING SOURCE
This publication was partially supported
by VISN 5 Pilot Research Grant (VISN 5;
VA Station: 688), VHA/VA Capitol Health
Care Network. Additional support was
provided by the VA Office of Academic

Sarcopenia in African American Veterans

Affiliations (OAA; 38 U.S.C 7406) and the
VA Office of Research and Development.

ACKNOWLEDGMENT
Any opinions or recommendations
expressed in this publication are those
of the authors and do not necessarily
reflect the view of the U.S. Department
of Veterans Affairs.

REFERENCES
Albu, J. B., Kovera, A. J., Allen, L., Wainwright,
M., Berk, E., Raja-Khan, N., et al. (2005).
Independent association of insulin resistance with
larger amounts of intermuscular adipose tissue
and a greater acute insulin response to glucose
in African American than in white nondiabetic
women. Am. J. Clin. Nutr. 82, 1210–1217.
Baumgartner, R. N. (2000). Body composition in
healthy aging. Ann. N.Y. Acad. Sci. 904, 437–448.
doi: 10.1111/j.1749-6632.2000.tb06498.x
Baumgartner, R. N., Koehler, K. M., Gallagher, D.,
Romero, L., Heymsfield, S. B., Ross, R. R., et al.
(1998). Epidemiology of sarcopenia among the
elderly in New Mexico. Am. J. Epidemiol. 147,
755–763. doi: 10.1093/oxfordjournals.aje.a009520
Bijlsma, A. Y., Meskers, C. G. M., van Heemst, D.,
Westendorp, R. G. J., de Craen, A. J. M., and Maier,
A. B. (2013). Diagnostic criteria for sarcopenia
relate differently to insulin resistance. Age (Dordr).
35, 2367–2375. doi: 10.1007/s11357-013-9516-0
Census Bureau. (2010). Public Use Microdata Areas
(PUMAs) [Internet]. Washington, DC: Census
Bureau. Available online at: http://www.census.
gov/geo/reference/puma.html
Chien, M.-Y., Huang, T.-Y., and Wu, Y.-T. (2008).
Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in
Taiwan. J. Am. Geriatr. Soc. 56, 1710–1715. doi:
10.1111/j.1532-5415.2008.01854.x
Cohn, S. H., Abesamis, C., Zanzi, I., Aloia, J. F.,
Yasumura, S., and Ellis, K. J. (1977). Body elemental composition: comparison between black and
white adults. Am. J. Physiol. 232, E419–E422.
Correa-de-Araujo, R., and Hadley, E. (2014).
Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of
sarcopenia and age-related muscle dysfunction.
J. Gerontol. A Biol. Sci. Med. Sci. 69, 591–594. doi:
10.1093/gerona/glt208
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M.,
Boirie, Y., Cederholm, T., Landi, F., et al. (2010).
Sarcopenia: European consensus on definition and
diagnosis: report of the European Working Group
on Sarcopenia in Older People. Age Ageing 39,
412–423. doi: 10.1093/ageing/afq034
Cruz-Jentoft, A. J., and Morley, J. E., (eds.). (2012).
Sarcopenia. Chichester: John Wiley and Sons.
Dam, T.-T., Peters, K. W., Fragala, M., Cawthon,
P. M., Harris, T. B., McLean, R., et al. (2014).
An evidence-based comparison of operational criteria for the presence of sarcopenia.
J. Gerontol. A Biol. Sci. Med. Sci. 69, 584–590. doi:
10.1093/gerona/glu013
Ettinger, B., Sidney, S., Cummings, S. R., Libanati,
C., Bikle, D. D., Tekawa, I. S., et al. (1997). Racial

Frontiers in Physiology | Striated Muscle Physiology

differences in bone density between young adult
black and white subjects persist after adjustment
for anthropometric, lifestyle, and biochemical differences. J. Clin. Endocrinol. Metab. 82, 429–434.
doi: 10.1210/jcem.82.2.3732
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin,
S., Morley, J. E., Newman, A. B., et al. (2011).
Sarcopenia: an undiagnosed condition in older
adults. Current consensus definition: prevalence,
etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir.
Assoc. 12, 249–256. doi: 10.1016/j.jamda.2011.
01.003
Fuller-Thomson, E., Nuru-Jeter, A., Minkler, M., and
Guralnik, J. M. (2009). Black-White disparities
in disability among older Americans: further
untangling the role of race and socioeconomic status. J. Aging Health 21, 677–698. doi:
10.1177/0898264309338296
Gomez-Cabello, A., Pedrero-Chamizo, R., Olivares,
P. R., Luzardo, L., Juez-Bengoechea, A., Mata, E.,
et al. (2011). Prevalence of overweight and obesity in non-institutionalized people aged 65 or over
from Spain: the elderly EXERNET multi-centre
study. Obes. Rev. 12, 583–592. doi: 10.1111/j.1467789X.2011.00878.x
Goodpaster, B. H., Carlson, C. L., Visser, M., Kelley,
D. E., Scherzinger, A., Harris, T. B., et al. (2001).
Attenuation of skeletal muscle and strength in
the elderly: the health ABC study. J. Appl. Physiol.
(1985) 90, 2157–2165. Available online at: http://
jap.physiology.org/cgi/pmidlookup?view=long&p
mid=11356778
Janssen, I., Baumgartner, R. N., Ross, R., Rosenberg,
I. H., and Roubenoff, R. (2004b). Skeletal muscle
cutpoints associated with elevated physical disability risk in older men and women. Am. J. Epidemiol.
159, 413–421. doi: 10.1093/aje/kwh058
Janssen, I., Heymsfield, S. B., and Ross, R. (2002).
Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am.
Geriatr. Soc. 50, 2074–2079. doi: 10.1046/j.15325415.2002.50216.x
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., and
Roubenoff, R. (2004a). The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 52,
80–85. doi: 10.1111/j.1532-5415.2004.52014.x
Kamel, H. K. (2003). Sarcopenia and aging. Nutr.
Rev. 61(5 pt 1), 157–167. doi: 10.1301/nr.2003.
may.157-167
Kan, G. A. V. (2009). Epidemiology and consequences
of sarcopenia. J. Nutr. Health Aging 13, 708–712.
doi: 10.1007/s12603-009-0201-z
Kane, R. L., Talley, K. M., Shamliyan, T., and
Pacala, J. T. (2011). Common Syndromes in Older
Adults Related to Primary and Secondary Prevention
[Internet]. Rockville, MD: Agency for Healthcare
Research and Quality (US) [cited 2013 Nov 19].
Available online at: http://www.ncbi.nlm.nih.gov/
books/NBK62074/
Kelly, T. L., Wilson, K. E., and Heymsfield, S.
B. (2009). Dual energy X-Ray absorptiometry body composition reference values from
NHANES. PLoS ONE 4:e7038. doi: 10.1371/journal.pone.0007038
Kleerekoper, M., Nelson, D. A., Peterson, E. L.,
Wilson, P. S., Jacobsen, G., and Longcope, C.
(1994). Body composition and gonadal steroids in

July 2014 | Volume 5 | Article 250 | 4

Harris-Love et al.

older white and black women. J. Clin. Endocrinol.
Metab. 79, 775–779.
Lorenzo, C. (2009). Body composition and physical
function in older adults. Obesity 17, 211–212. doi:
10.1038/oby.2008.506
Malmstrom, T. K., Miller, D. K., Herning, M. M.,
and Morley, J. E. (2013). Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged
African Americans. J. Cachexia Sarcopenia Muscle
4, 179–186. doi: 10.1007/s13539-013-0106-x
Miljkovic, I., Cauley, J. A., Petit, M. A., Ensrud,
K. E., Strotmeyer, E., Sheu, Y., et al. (2009).
Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry. J. Clin.
Endocrinol. Metab. 94, 2735–2742. doi: 10.1210/jc.
2008-2541
Miljkovic-Gacic, I., Gordon, C. L., Goodpaster, B.
H., Bunker, C. H., Patrick, A. L., Kuller, L. H.,
et al. (2008). Adipose tissue infiltration in skeletal
muscle: age patterns and association with diabetes
among men of African ancestry. Am. J. Clin. Nutr.
87, 1590–1595.
Miller, D. K., Wolinsky, F. D., Malmstrom, T.
K., Andresen, E. M., and Miller, J. P. (2005).
Inner city, middle-aged African Americans
have excess frank and subclinical disability.
J. Gerontol. A Biol. Sci. Med. Sci. 60, 207–212. doi:
10.1093/gerona/60.2.207
Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos,
V., Bauer, J., Bhasin, S., et al. (2011). Sarcopenia
with limited mobility: an international consensus. J. Am. Med. Dir. Assoc. 12, 403–409. doi:
10.1016/j.jamda.2011.04.014
Murphy, R. A., Ip, E. H., Zhang, Q., Boudreau, R.
M., Cawthon, P. M., Newman, A. B., et al. (2013).
Transition to sarcopenia and determinants of transitions in older adults: a population-based study.
J. Gerontol. A Biol. Sci. Med. Sci. 69, 751–758. doi:
10.1093/gerona/glt131
National Center for Veterans Analysis and
Statistics. (2011). Profile of Veterans: 2009
[Internet]. Washington, DC: NCVAS. Available
online at: http://www.va.gov/vetdata/docs/Special
Reports/Profile_of_Veterans_2009_FINAL.pdf
Newman, A. B., Kupelian, V., Visser, M., Simonsick,
E., Goodpaster, B., Nevitt, M., et al. (2003).
Sarcopenia: alternative definitions and associations with lower extremity function. J. Am.
Geriatr. Soc. 51, 1602–1609. doi: 10.1046/j.15325415.2003.51534.x

www.frontiersin.org

Sarcopenia in African American Veterans

Nindl, B. C., Kraemer, W. J., Emmert, W. H.,
Mazzetti, S. A., Gotshalk, L. A., Putukian, M.,
et al. (1998). Comparison of body composition assessment among lean black and white
male collegiate athletes. Med. Sci. Sports Exerc.
30, 769–776. doi: 10.1097/00005768-19980500000020
Ortiz, O., Russell, M., Daley, T. L., Baumgartner, R. N.,
Waki, M., Lichtman, S., et al. (1992). Differences
in skeletal muscle and bone mineral mass between
black and white females and their relevance to estimates of body composition. Am. J. Clin. Nutr. 55,
8–13.
Sayer, A. A., Dennison, E. M., Syddall, H. E., Gilbody,
H. J., Phillips, D. I. W., and Cooper, C. (2005). Type
2 diabetes, muscle strength, and impaired physical
function: the tip of the iceberg? Diabetes Care 28,
2541–2542. doi: 10.2337/diacare.28.10.2541
Schrager, M. A., Metter, E. J., Simonsick, E., Ble,
A., Bandinelli, S., Lauretani, F., et al. (2007).
Sarcopenic obesity and inflammation in the
InCHIANTI study. J. Appl. Physiol. 102, 919–925.
doi: 10.1152/japplphysiol.00627.2006
Schutte, J. E., Townsend, E. J., Hugg, J., Shoup, R.
F., Malina, R. M., and Blomqvist, C. G. (1984).
Density of lean body mass is greater in blacks than
in whites. J. Appl. Physiol. 56, 1647–1649.
Song, M.-Y., Ruts, E., Kim, J., Janumala, I.,
Heymsfield, S., and Gallagher, D. (2004).
Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women.
Am. J. Clin. Nutr. 79, 874–880. Available online at:
http://www.ajcn.org/cgi/pmidlookup?view=long&
pmid=15113728
Srikanthan, P., Hevener, A. L., and Karlamangla, A. S.
(2010). Sarcopenia exacerbates obesity-associated
insulin resistance and dysglycemia: findings from
the National Health and Nutrition Examination
Survey III. PLoS ONE 5:e10805. doi: 10.1371/journal.pone.0010805
VA Office of the Actuary. (2011). The Veteran
Population Projection Model 2011. Washington,
DC: OACT.
Visser, M., Kritchevsky, S. B., Goodpaster, B. H.,
Newman, A. B., Nevitt, M., Stamm, E., et al.
(2002). Leg muscle mass and composition in
relation to lower extremity performance in men
and women aged 70 to 79: the health, aging
and body composition study. J. Am. Geriatr.
Soc. 50, 897–904. doi: 10.1046/j.1532-5415.2002.
50217.x

Visser, M., Newman, A. B., Nevitt, M. C., Kritchevsky,
S. B., Stamm, E. B., Goodpaster, B. H., et al.
(2000). Reexamining the sarcopenia hypothesis - muscle mass versus muscle strength. Ann.
N.Y. Acad. Sci. 904, 456–461. doi: 10.1111/j.17496632.2000.tb06500.x
Visser, M., and Schaap, L. A. (2011). Consequences of
sarcopenia. Clin. Geriatr. Med. 27, 387–399. doi:
10.1016/j.cger.2011.03.006
Wagner, D. R., and Heyward, V. H. (2000). Measures
of body composition in blacks and whites:
a comparative review. Am. J. Clin. Nutr. 71,
1392–1402. Available online at: http://www.ajcn.
org/cgi/pmidlookup?view=long&pmid=10837277
Wagner, D. R., Heyward, V. H., Kocina, P. S.,
Stolarczyk, L. M., and Wilson, W. L. (1997).
Predictive accuracy of BIA equations for estimating fat-free mass of black men. Med. Sci.
Sports Exerc. 29, 969–974. doi: 10.1097/00005768199707000-00018
Zillikens, M. C., and Conway, J. M. (1990).
Anthropometry in blacks: applicability of generalized skinfold equations and differences in fat
patterning between blacks and whites. Am. J. Clin.
Nutr. 52, 45–51.
Conflict of Interest Statement: The authors declare
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 06 May 2014; paper pending published: 06
June 2014; accepted: 16 June 2014; published online: 07
July 2014.
Citation: Harris-Love MO, Adams B, Hernandez HJ,
DiPietro L and Blackman MR (2014) Disparities in
the consequences of sarcopenia: implications for African
American Veterans. Front. Physiol. 5:250. doi: 10.3389/
fphys.2014.00250
This article was submitted to Striated Muscle Physiology,
a section of the journal Frontiers in Physiology.
Copyright © 2014 Harris-Love, Adams, Hernandez,
DiPietro and Blackman. This is an open-access article
distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply
with these terms.

July 2014 | Volume 5 | Article 250 | 5

